The second-largest stablecoin — a cryptocurrency that is pegged to a fiat currency — USCD depegged from the dollar, hitting an all-time low of around 88 cents over the weekend. While the coin has rebounded, it's still hovering just below the peg and could face additional volatility amid the ongoing collapse of Silicon Valley Bank. USCD reportedly held a significant amount of reserves at the embattled bank.
NEW MIGRAINE TREATMENT
The FDA has approved a new nasal spray for adults who suffer migraines. Pfizer said the spray, called Zavzpret, is considered a rapid rescue treatment and could relieve migraine pain within 15 minutes. The spray is also an alternative for people who have heart disease and other conditions that are preventing them from safely using other migraine treatments.
SLASHER SUCCESS
Scream VI topped the charts this weekend with $44.5 million dollars in ticket sales. It's the best debut in the franchise's history and a surprise box office success in the usually quiet month of March. The film follows the survivors of the last spate of Ghostface murders as they pursue a fresh start in New York City. Last year, the fifth Scream entry made about $30 million in ticket sales over a four-day holiday weekend
Joby CPO Eric Allison discusses the UAE’s historic EVTOL take off, marking Dubai as the launchpad for global air taxi adoption and Joby’s commercial readiness.
CFRA’s Angelo Zino joins us to unpack Meta’s Superintelligence Labs and what it means for the future of AI, innovation, and the company’s bold new direction.
AIRO CEO Joe Burns and Executive Chairman Chirinjeev Kathuria talks the future of aerospace, drones, and urban air mobility through innovation and synergy.
NYC's mayoral race heats up with a socialist candidate aiming to make the city affordable—and rattling the financial sector. Plus: Coinbase's prospects.
Mark Hamrick of Bankrate discusses the jobs market, AI's growing impact on employment, and how markets are reacting to today’s surprising payroll data.
Amanda Chu of POLITICO reveals how lawmakers are betting millions on pharma stocks even as Trump threatens tariffs and demands steep drug price cuts. Watch!
